Skip to main content

EU Panel Recommends Adjuvant Nivolumab for Select Esophageal, GEJ Cancers

No Comments yet!

Your Email address will not be published.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2021 Esophageal Cancer Education Foundation